期刊文献+

新疆汉族和维吾尔族鼻咽癌组织的PCR和免疫组化检测比较 被引量:1

Detection of EBV DNA,EBNA2 and LMP-1 in Tumor Tissues of Han and Uygur Patients with Nosopharyngeal Carcinoma in Xinjiang
原文传递
导出
摘要 目的 :了解新疆汉族维吾尔 (维 )族鼻咽癌 (NPC)发病因素的差别。 方法 :用 PCR与免疫组化技术对73例 NPC组织 (汉族 4 1例、维族 3 2例 )分别进行 EB病毒脱氧核糖核酸 (EBV-DNA )、EB病毒核抗原(EBNA2 )、潜伏膜蛋白 (LMP- 1 )检测。结果 :EBV- DNA阳性检出率汉族为 48.8% (2 0 /41 ) ,维族59.4% (1 9/32 ) ;EBNA2 表达汉族 43.9% (1 8/41 ) ,维族 43.8% (1 4 /32 ) ,两民族间无显著性差异(P >0 .0 5)。 LMP- 1表达 ,汉族 34.1 % (1 4 /41 ) ,明显低于维族 71 .9% (2 3/32 ) (P <0 .0 5)。在EBV- DNA阳性病例中 ,LMP- 1表达汉族为 40 .0 % (8/2 0 ) ,也明显低于维族 78.9% (1 5/1 9) (P<0 .0 5) ;EBNA2 表达两民族间无统计学差异 (P >0 .0 5)。结论 :新疆 NPC的发生与 EB病毒感染有相关性 ;LMP- 1在维族鼻咽上皮细胞恶性转化过程中 ,具有较汉族更重要的作用。 Objective:To investigate the possible difforences of human nosopharyngeal carcinogenesis between Han and Uygur patients in xinjiang.Method:Detection of EBV DNA,EBNA2 and LMP 1 in tumor tissues of 73 patients (Han 41,uygur 32) with nosopharyngeal carcinoma (NPC) were peroformed by PCR and immunohistochemistry.Result:Tho positive rate of EBV DNA,EBNA2 expression was 48.2 %(20/41), 43.9 %(18/41) in Han and 59.3 %(19/32), 43.7 %(14/32) in Uygur respectively,no significant difference was found (P> 0.05 ).Expression of LMP 1 in NPC,in both positive and negative EBV DNA specimens,was higher in Uygur ( 78.9 %) than that in Han (40%) (P< 0.05 ),Conclusion:The EBV infection may involve in nosophayyngoal carcinogonosis in xinjiang;the LMP 1 of EBV could be a more critical factor in malignant transformation of normal nosopharyngeal epithelium in uygur people than in han Chinese.
出处 《临床耳鼻咽喉科杂志》 CSCD 2000年第2期76-77,共2页 Journal of Clinical Otorhinolaryngology
基金 新疆医科大学第一附属医院科研基金
关键词 鼻咽癌 EB病毒 DNA EBNA2 免疫组化 Nasopharyngeal neoplasms DNA,Epstein Barr virus EBV nuclear antigen Latent membrane protein
  • 相关文献

参考文献4

二级参考文献68

  • 1刘春梅,李发琪,王智彪.高强度聚焦超声空化效应的研究进展[J].临床超声医学杂志,2007,9(4):233-235. 被引量:11
  • 2Ferlay J, Soerjomataram I,Dikshit R,et al. Cancerincidence and mortality worldwide : sources, methods andmajor patterns in GLOBOCAN 2012 [ J ]. Int J Cancer,2015,136(5) :E359-E386.
  • 3European Association for the Study of the Liver, EuropeanOrganisation for research and Treatment of Cancer. EASL-EORTC clinical practice guidelines : management ofhepatocellular carcinoma [ J ]. J Hepatol, 2012, 56 :908-943.
  • 4Li D, Kang J, Madoff DC. Locally ablative therapies forprimary and metastatic liver cancer [ J ]. Expert RevAnticancer Ther, 2014,14(8) :931-945.
  • 5Sofocleous CT, Petre EN, Gonen M,et al. CT-guidedRadiofrequency Ablation as a Salvage Treatment ofColorectal Cancer Hepatic Metastases Developing afterHepatectomy [ J ]. J Vase Interv Radiol, 2011,22 ( 6 ):755-761.
  • 6Zhou YM,Zhao YF, Li B,et al. Meta-analysis ofradiofrequency ablation versus hepatic resection for smallhepatocellular carcinomaf J]. BMC Gastroenterology ,2010,10(1):78.
  • 7Rossi S, Ravetta V, Rosa L, et al. RepeatedRadiofrequency Ablation for Management of Patients withCirrhosis with Small Hepatocellular Carcinomas : A Long-Term Cohort Study[ J]. Hepatology,2011,53( 1) :136-147.
  • 8Shiina S, Tateishi R, Arano T, et al. RadiofrequencyAblation for Hepatocellular Carcinoma : 10-Year Outcomeand Prognostic Factors [ J ]. Am J Gastroenterol, 2012,107(4) :569-577.
  • 9Francica G, Saviano A, De Sio I,et al. Long-termeffectiveness of Radiofrequency Ablation for solitary smallHepatocellular Carcinoma : A retrospective analysis of 363patients[ J]. Dig Liver Dis,2013,45(4) :336-341.
  • 10Lu MD,Xu HX,Xie XY,et al. Percutaneous microwaveand radiofrequency ablation for hepatocellular carcinoma : aretrospective comparative study[ J]. J Gastroe nterol,2005,40(11) :1054-1060.

共引文献31

同被引文献21

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部